213 related articles for article (PubMed ID: 6756729)
1. C-peptide antibodies induced by bovine insulin therapy.
Reeves WG; Douglas CA
Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of insulin of various origins.
Reeves WG
Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
[No Abstract] [Full Text] [Related]
3. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
[No Abstract] [Full Text] [Related]
4. Insulin antibodies induced by bovine insulin therapy.
Reeves WG; Kelly U
Clin Exp Immunol; 1982 Oct; 50(1):163-70. PubMed ID: 6756728
[TBL] [Abstract][Full Text] [Related]
5. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
6. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
Andreani D; Iavicoli M; Colletti A; Menzinger G
Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
[No Abstract] [Full Text] [Related]
7. [A method for determination of proinsulin levels in serum using both insolubilized anti-insulin antibody and anti-C-peptide antibody].
Sasakuma F; Hasegawa K; Ishikawa O; Matumiya K; Yagi K; Kitamura H; Kojima J
Rinsho Byori; 1992 Jul; 40(7):769-74. PubMed ID: 1507496
[TBL] [Abstract][Full Text] [Related]
8. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
Fineberg SK
Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
[No Abstract] [Full Text] [Related]
9. C-peptide-measurement: a simple method for the improvement of specificity.
Krause U; von Erdmann B; Atzpodien W; Beyer J
J Immunoassay; 1981; 2(1):33-44. PubMed ID: 7026618
[TBL] [Abstract][Full Text] [Related]
10. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of proinsulin-specific antibodies in diabetic patients.
Kumar D; Miller LV
Horm Metab Res; 1973 Jan; 5(1):1-3. PubMed ID: 4735948
[No Abstract] [Full Text] [Related]
12. Elevated circulating proinsulin levels in insulin-requiring diabetic patients.
Block MB; Mako M; Steiner DF; Rubenstein AH
J Lab Clin Med; 1971 Nov; 78(5):811-2. PubMed ID: 5316079
[No Abstract] [Full Text] [Related]
13. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
[TBL] [Abstract][Full Text] [Related]
14. [The study of insulin antibodies in different forms of diabetes mellitus].
Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
[No Abstract] [Full Text] [Related]
15. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
[No Abstract] [Full Text] [Related]
16. Production of peptide antisera specific for mouse and rat proinsulin C-peptide 2.
Blume N; Madsen OD; Kofod H; Dyrberg T
Biomed Biochim Acta; 1990; 49(12):1247-51. PubMed ID: 1711321
[TBL] [Abstract][Full Text] [Related]
17. Free C-peptide immunoreactivity in insulin-treated diabetics.
Oyama H; Horino M; Nakashima Y; Tenku A; Matsumura S
Endocrinol Jpn; 1977 Apr; 24(2):223-7. PubMed ID: 872824
[No Abstract] [Full Text] [Related]
18. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
19. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
Weber HU; Sourisseau D; Zahnd GR
Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
[No Abstract] [Full Text] [Related]
20. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
Göbel P; Kramer W; Heni F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
